With a changing of the guard, the Federal Trade Commission (FTC) is undergoing some major restructuring, gearing up to be an aggressive antitrust watchdog. All told, it’s not just Big Tech and pharmaceutical companies that should be on alert.

Learn More
Already a member? Sign in to an existing account.

Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,...